OXURION
LIVE

Serial Number

79239267

Owner

ThromboGenics

Attorney

Martin W. Schiffmiller

Filing Date

Jun 25, 2018

Add to watchlist:

No watchlists yet
View on USPTO

OXURION Trademark

Serial Number: 79239267 • Registration: 5772180

OXURION is a trademark filed by ThromboGenics on June 25, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ThromboGenics

Gaston Geenslaan 1

Entity Type: 32

Oxurion NV (10 trademarks)

Gaston Geenslaan 1

Entity Type: 32

Trademark Details

Filing Date

June 25, 2018

Registration Date

June 11, 2019

Published for Opposition

March 26, 2019

Cancellation Date

December 26, 2025

Goods & Services

Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals

Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
CANCELLED SECTION 71
Dec 26, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 11, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 11, 2019 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 13, 2019 ADCH
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Mar 23, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 6, 2019 OP2R
ASSIGNED TO LIE
Feb 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2019 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2019 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2019 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 13, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 28, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 23, 2018 REPR